Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Acorda Therapeutics Inc | ACOR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.661 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.661 | 0.661 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.6116 - 24.196 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.661 | USD |
Acorda Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 821.03k | - | - | - | -0.38 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Acorda Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/15/2024 | 16:03 | Business Wire | Acorda Therapeutics Announces Delisting from Nasdaq |
| 4/03/2024 | 16:30 | Business Wire | Acorda Therapeutics Announces Nasdaq Delisting Notification |
| 4/01/2024 | 17:35 | Business Wire | Acorda Therapeutics and Merz Announce Signing of “Stalking.. |
| 4/01/2024 | 15:01 | Business Wire | Acorda Cancels Q4 and Year End 2023 Earnings Conference Call.. |
| 3/25/2024 | 15:01 | Business Wire | Acorda Fourth Quarter/Year End 2023 Update:.. |
| 1/11/2024 | 07:33 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/11/2024 | 07:01 | Business Wire | Acorda Therapeutics to Regain Global Commercialization.. |
| 12/01/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 15:01 | Business Wire | Acorda Therapeutics Reports Third Quarter 2023 Financial.. |
| 11/06/2023 | 15:01 | Business Wire | Acorda Third Quarter 2023 Update: Webcast/Conference Call.. |
| 11/06/2023 | 07:00 | Business Wire | Acorda Therapeutics Announces Biopas Laboratories Submission.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACOR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 13.74 | 13.74 | 0.6116 | 1.86 | 845,926 | -13.08 | -95.19% |
| 3 Months | 15.85 | 16.73 | 0.6116 | 2.06 | 161,423 | -15.19 | -95.83% |
| 6 Months | 10.01 | 18.00 | 0.6116 | 2.48 | 69,938 | -9.35 | -93.40% |
| 1 Year | 9.60 | 24.196 | 0.6116 | 15.12 | 249,001 | -8.94 | -93.11% |
| 3 Years | 94.00 | 127.20 | 0.6116 | 27.21 | 718,293 | -93.34 | -99.30% |
| 5 Years | 1,338.00 | 1,458.00 | 0.6116 | 143.54 | 1,353,310 | -1,337.34 | -99.95% |
Acorda Therapeutics Description
| Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States. |
